Tessera Therapeutics
UEI: XFPJKGA6ARL1
• CAGE: 9WU32
Overview
Awardee Type
Parent
Company Description
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing™, a new biotechnology designed to offer scientists and doctors the…
Name
Tessera Therapeutics
Headquarters
Somerville, MA
United States
United States
Most Recent Award
Sept. 23, 2025
Calculating
Federal contract recipient
TESSERA THERAPEUTICS, INC
(UEI XFPJKGA6ARL1, CAGE 9WU32)
is headquartered in Somerville MA.
The corporation
was founded in August 2018 and
federally registered in
May 2024.
Federal Award Analysis
Tessera Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
TESSERA THERAPEUTICS, INC
UEI
XFPJKGA6ARL1
CAGE Code
9WU32
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Assistance Awards
Date Founded
Aug. 30, 2018
Initial Registration
May 1, 2024
Last Registration
May 22, 2025
Registration Activation
May 21, 2025
Registration Expiration
May 19, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
None Reported
Accepts Credit Cards
No